Intuitive Surgical Stock Now 16% Cheaper, Time To Buy

Intuitive Surgical (ISRG) stock might be a good buy now. Why? Because you get high margins – reflective of pricing power and cash generation capacity – for a discounted price. Companies like this generate consistent, predictable profits and cash flows, which reduce risk and allow capital to be reinvested. The market tends to reward that.

What Is Happening With ISRG

ISRG is up 3.9% so far this year, but is actually 16% cheaper based on its P/S (Price-to-Sales) ratio compared to 1 year ago.

Here is what’s going well for the company. The year-to-date return is 4.87%. Strong adoption of the da Vinci V system led to 240 placements in Q3 2025, boosting the installed base to nearly 10,800 systems. This, along with international expansion, drove total worldwide procedure growth of 20%, significantly increasing recurring instrument and accessory sales. Recent FDA clearance for da Vinci SP in three new procedures further expands market opportunities. Management now expects 2025 da Vinci procedure growth of 17-17.5% and raised gross margin guidance to 67-67.5%, reflecting efficient cost control and leverage from higher utilization.

ISRG Has Strong Fundamentals

• Recent Profitability: Nearly 30.8% operating cash flow margin and 29.3% operating margin LTM.
• Long-Term Profitability: About 27.8% operating cash flow margin and 26.7% operating margin last 3-year average.
• Revenue Growth: Intuitive Surgical saw growth of 22.2% LTM and 16.3% last 3-year average, but this is not a growth story
• Available At Discount: At P/S multiple of 16.6, ISRG stock is available at a 16% discount vs 1 year ago.

Below is a quick comparison of ISRG fundamentals with S&P medians.

*LTM: Last Twelve Months

Don’t Expect A Slam Dunk, Though

While ISRG stock may be a compelling investment opportunity, it’s always helpful to be aware of a stock’s history of drawdown. ISRG plunged 82% in the Dot-Com crash and 76% during the Global Financial Crisis. The inflation shock dragged it down nearly 50%, while the Covid selloff hit around 40%. Even the 2018 correction meant a 24% drop. The stock has strong fundamentals, but these numbers show it’s still vulnerable when markets turn sour. But the risk is not limited to major market crashes. Stocks fall even when markets are good – think events like earnings, business updates, outlook changes. Read ISRG Dip Buyer Analyses to see how the stock has recovered from sharp dips in the past.

If you want more details, read Buy or Sell ISRG Stock.

How We Arrived At ISRG Stock

ISRG piqued our interest because it meets the following criteria:

1. Greater than $10 Bil in market cap
2. High CFO (cash flow from operations) margins or operating margins
3. Meaningfully declined in valuation over the past 1 year

But if ISRG doesn’t look good enough to you, here are other stocks that also check all these boxes:

1. Visa (V)
2. Salesforce (CRM)
3. T-Mobile US (TMUS)

Notably, a portfolio that was built starting 12/31/2016 with stocks that fulfil the criteria above would have performed as follows:

• Average 12-month forward returns of nearly 19%
• 12-month win rate (percentage of picks returning positive) of about 72%

The Right Way To Invest Is Through Portfolios

Stocks can jump or crash but long term success comes from staying invested. The right portfolio helps you ride gains and cushion single stock drops

The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 – the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.